Oncopeptides AB Partners with SD Pharma to Expand Pepaxti’s Reach in Spain
Oncopeptides AB has formed a strategic partnership with SD Pharma to expand the reach of its cancer treatment, Pepaxti, in Spain, marking a significant milestone in its mission to combat cancer.
3 minutes to read